Your browser doesn't support javascript.
loading
Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results.
Agarwal, Rajiv; Anker, Stefan D; Filippatos, Gerasimos; Pitt, Bertram; Rossing, Peter; Ruilope, Luis M; Boletis, John; Toto, Robert; Umpierrez, Guillermo E; Wanner, Christoph; Wada, Takashi; Scott, Charlie; Joseph, Amer; Ogbaa, Ike; Roberts, Luke; Scheerer, Markus F; Bakris, George L.
Afiliação
  • Agarwal R; Richard L. Roudebush VA Medical Center and Indiana University, Indianapolis, IN, USA.
  • Anker SD; Department of Cardiology (CVK) and Berlin Institute of Health Center for Regenerative Therapies, German Centre for Cardiovascular Research Partner Site Berlin, Charité Universitätsmedizin, Berlin, Germany.
  • Filippatos G; National and Kapodistrian University of Athens, School of Medicine, Department of Cardiology, Attikon University Hospital, Athens, Greece.
  • Pitt B; Department of Medicine, University of Michigan School of Medicine, Ann Arbor, MI, USA.
  • Rossing P; Steno Diabetes Center Copenhagen, Gentofte, Denmark.
  • Ruilope LM; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Boletis J; Cardiorenal Translational Laboratory and Hypertension Unit, Institute of Research imas12, Madrid, Spain.
  • Toto R; CIBER-CV, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Umpierrez GE; Faculty of Sport Sciences, European University of Madrid, Madrid, Spain.
  • Wanner C; Faculty of Medicine, Laiko General Hospital, University of Athens, Greece.
  • Wada T; Department of Internal Medicine, UT Southwestern, Dallas, TX, USA.
  • Scott C; Division of Endocrinology, Metabolism, Emory University School of Medicine, Atlanta, GA, USA.
  • Joseph A; Medizinische Klinik und Poliklinik 1, Schwerpunkt Nephrologie, Universitätsklinik Würzburg, Würzburg, Germany.
  • Ogbaa I; Department of Nephrology, Kanazawa University, Ishikawa, Japan.
  • Roberts L; Data Science and Analytics, Bayer PLC, Reading, UK.
  • Scheerer MF; Cardiology and Nephrology Clinical Development, Bayer AG, Berlin, Germany.
  • Bakris GL; US Medical Affairs-Cardiovascular and Renal, Bayer U.S. LLC, Wayne, NJ, USA.
Nephrol Dial Transplant ; 37(7): 1261-1269, 2022 06 23.
Article em En | MEDLINE | ID: mdl-34850173

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 6_cardiovascular_diseases / 6_chronic_kidney_disease / 6_endocrine_disorders / 6_other_circulatory_diseases Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas / Insuficiência Renal Crônica / Inibidores do Transportador 2 de Sódio-Glicose / Insuficiência Cardíaca Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Nephrol Dial Transplant Assunto da revista: NEFROLOGIA / TRANSPLANTE Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 6_cardiovascular_diseases / 6_chronic_kidney_disease / 6_endocrine_disorders / 6_other_circulatory_diseases Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas / Insuficiência Renal Crônica / Inibidores do Transportador 2 de Sódio-Glicose / Insuficiência Cardíaca Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Nephrol Dial Transplant Assunto da revista: NEFROLOGIA / TRANSPLANTE Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
...